October 6, 2021
In February 2020, RegenMed and StemMedical® signed a deal to create a Circle for their proprietary stem cell-enriched lipofilling method for breast, facial, buttock augmentation and artificial implant replacement where a mix of autologous fat and autologous laboratory-expanded stem cells ASC (adipose tissue-derived stem cells) is injected with approximately 100% fat graft survival.
The Circle has two principal objectives:
This GDPR-compliant Circle is in currently in use by three StemMedical® licensed plastic surgeons and has already enrolled many of their patients. First patient follow-up results are a few months away.
StemMedical® is first in the world to commercially offer stem cell-based products for the cosmetic industry and is setting its sights on expanding through select countries in Europe over the next few years, where the Circle will play a pivotal role in attracting practitioners and their patients to these novel, evidence-based procedures.
To learn more information about StemMedical®, visit www.stemmedical.com.
March 28, 2023
Statistical Significance and Clinical Relevance are two important concepts in the field of medicine, and particularly in clinical research. Being a bit more specific, statistical significance refers to the likelihood that a result is not due to chance.
March 17, 2023
Real-world evidence (RWE) is valuable not only for regulatory compliance, clinical decision-making and tracking adverse events. It can also drive patient engagement, profitability and professional advancement.
January 27, 2023
In this newsletter, we summarize the work of leading physicians as they develop clinical decision support for common musculoskeletal pathologies. Through the quality improvement and pragmatic studies embedded in their Circles, those clinicians are generating sustained financial and professional value for themselves, and improving patient care, with minimum burden. Moreover, their Circles are often supported by industry.